Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diagnosing malignant hyperthermia susceptibility by detection of abnormal proteolytic enzyme digestion fragments of the ryanodine receptor

Diagnosing malignant hyperthermia susceptibility by detection of abnormal proteolytic enzyme digestion fragments of the ryanodine receptor

US Patent 5242801 · Granted Sep 7, 1993

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, ed2018
Inhibitors of phosphodiesterase type 5A for treating or preventing muscle diseas2016
Method of detecting equine polysaccharide storage myopathy2012
Method of detecting canine exercise-induced collapse2012
Increasing functional glycosylation of alpha-dystroglycan in the treatment of mu2012
Method of detecting equine glycogen storage disease IV2006
Assay for propensity for canine malignant hyperthermia2003
Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan 2002
Genes encoding neuronal voltage-gated calcium channel gamma subunits2002
Receptor for Mycobacterium leprae and methods of use thereof2001
Gene replacement therapy for muscular dystrophy2001
.delta.-sarcoglycan antibodies2001